Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.

about

Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q52821559

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@en

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@nl

type

Item

label

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@en

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@nl

prefLabel

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@en

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@nl

P1476

Pro-angiogenic gene expression ...... ear-cell renal cell carcinoma.

@en

P2093

Annelies Verbiest

http://www.w3.org/2001/XMLSchema#string

Arnaud Méjean

http://www.w3.org/2001/XMLSchema#string

Aurélien de Reynies

http://www.w3.org/2001/XMLSchema#string

Benoit Beuselinck

http://www.w3.org/2001/XMLSchema#string

Brigitte Laguerre

http://www.w3.org/2001/XMLSchema#string

Clément Meiller

http://www.w3.org/2001/XMLSchema#string

Evelyne Lerut

http://www.w3.org/2001/XMLSchema#string

Gabrielle Couchy

http://www.w3.org/2001/XMLSchema#string

Jessica Zucman-Rossi

http://www.w3.org/2001/XMLSchema#string

Stéphane Oudard

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Integrated molecular analysis of clear-cell renal cell carcinoma.

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.

BAP1 loss defines a new class of renal cell carcinoma.

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.

Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.

P304

498-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1388927

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Schöffski

Nathalie Rioux-Leclercq

Maarten Albersen

Jean-Jacques Patard

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29095068

http://www.w3.org/2001/XMLSchema#string